Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

IPHAIPHA
12 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in INNATE PHARMA S A

CITADEL ADVISORS LLC holds 12,441 shares of IPHA (INNATE PHARMA S A), worth $22,891 as of 2026-Q2. This is a new position.

Current Value

$22,891

Current Shares

12,441

Total Value Change

-$86,109

Total Shares Change

-12,809

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
12,441
-
$22,8910.0%$1.84
29
2025-Q4
Exited
0
-100.0%
$00.0%$1.74
0
2025-Q3
Decreased
20,042
-24.7%
$39,0820.0%$1.82
0
2025-Q2
Increased
26,617
+9.7%
$46,5800.0%$1.85
15
2025-Q1
Increased
24,267
+104.7%
$43,1950.0%$1.98
22
2024-Q4
Decreased
11,853
-44.3%
$21,9280.0%$1.95
0
2024-Q3
Decreased
21,267
-9.6%
$48,7010.0%$2.20
0
2024-Q2
New
23,527
-
$45,6420.0%$1.94
31
2023-Q3
Exited
0
-100.0%
$00.0%$2.53
0
2023-Q2
New
13,281
-
$41,7020.0%$3.13
31
2021-Q2
Exited
0
-100.0%
$00.0%$3.58
0
2021-Q1
New
25,250
-
$109,0000.0%$4.29
33

Other major holders of IPHA: WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used